![Mats Uno Olsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mats Uno Olsson
Direttore/Membro del Consiglio presso RespiVert Ltd.
Posizioni attive di Mats Uno Olsson
Società | Posizione | Inizio | Fine |
---|---|---|---|
RespiVert Ltd.
![]() RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 09/12/2010 | - |
Storia della carriera di Mats Uno Olsson
Precedenti posizioni note di Mats Uno Olsson
Società | Posizione | Inizio | Fine |
---|---|---|---|
XO1 Ltd.
![]() XO1 Ltd. Medical/Nursing ServicesHealth Services XO1 Ltd. develops a novel anticoagulant drug. The firm operates as a biopharmaceutical company. The company was founded by David J. Grainger on February 28, 2013 and is headquartered in High Wycombe, the United Kingdom. | Direttore/Membro del Consiglio | 18/03/2015 | - |
Statistiche
Distribuzione geografica
Regno Unito | 3 |
Posizioni
Director/Board Member | 2 |
Settori
Health Services | 2 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
XO1 Ltd.
![]() XO1 Ltd. Medical/Nursing ServicesHealth Services XO1 Ltd. develops a novel anticoagulant drug. The firm operates as a biopharmaceutical company. The company was founded by David J. Grainger on February 28, 2013 and is headquartered in High Wycombe, the United Kingdom. | Health Services |
RespiVert Ltd.
![]() RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Distribution Services |
- Borsa valori
- Insiders
- Mats Uno Olsson
- Esperienza